long term use of semaglutide Long-term weight loss effects in obesity without diabetes in the SELECT trial Zepbound vs. Semaglutide vs. Wegovy:

Recent Findings GLP-1 agonists may be associated with breast changes and symptoms that warrant further breast imaging, including supplemental screening and/or for problem solving in the appropriate clinical scenario

Dosing and Administration Retatrutide is administered as a once-weekly subcutaneous injection, with a careful titration schedule designed to minimize side effects

Despite these findings, a clear link has yet to be established, and much of the evidence remains inconsistent

Researchers conducted a prospective single-center cohort study of adults with a BMI of 27 kg/m2 or higher using liraglutide (Victoza/Saxenda, Novo Nordisk) or semaglutide (Ozempic/Wegovy, Novo Nordisk)